BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22136321)

  • 1. Role of aldosterone on lung structural remodelling and right ventricular function in congestive heart failure.
    Chabot A; Jiang BH; Shi Y; Tardif JC; Dupuis J
    BMC Cardiovasc Disord; 2011 Dec; 11():72. PubMed ID: 22136321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PBI-4050 reduces pulmonary hypertension, lung fibrosis, and right ventricular dysfunction in heart failure.
    Nguyen QT; Nsaibia MJ; Sirois MG; Calderone A; Tardif JC; Fen Shi Y; Ruiz M; Daneault C; Gagnon L; Grouix B; Laurin P; Dupuis J
    Cardiovasc Res; 2020 Jan; 116(1):171-182. PubMed ID: 30753422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineralocorticoid receptor antagonism attenuates experimental pulmonary hypertension.
    Preston IR; Sagliani KD; Warburton RR; Hill NS; Fanburg BL; Jaffe IZ
    Am J Physiol Lung Cell Mol Physiol; 2013 May; 304(10):L678-88. PubMed ID: 23457185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single measurement of troponin T for early prediction of infarct size, congestive heart failure, and pulmonary hypertension in an animal model of myocardial infarction.
    Jiang BH; Nguyen QT; Tardif JC; Shi Y; Dupuis J
    Cardiovasc Pathol; 2011; 20(3):e85-9. PubMed ID: 20537565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
    Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
    Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone.
    Mulder P; Mellin V; Favre J; Vercauteren M; Remy-Jouet I; Monteil C; Richard V; Renet S; Henry JP; Jeng AY; Webb RL; Thuillez C
    Eur Heart J; 2008 Sep; 29(17):2171-9. PubMed ID: 18586661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction.
    Milliez P; Deangelis N; Rucker-Martin C; Leenhardt A; Vicaut E; Robidel E; Beaufils P; Delcayre C; Hatem SN
    Eur Heart J; 2005 Oct; 26(20):2193-9. PubMed ID: 16141258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role of CNS effects of aldosterone in cardiac remodeling post-myocardial infarction in rats.
    Lal A; Veinot JP; Leenen FH
    Cardiovasc Res; 2004 Dec; 64(3):437-47. PubMed ID: 15537497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bosentan does not improve pulmonary hypertension and lung remodeling in heart failure.
    Jiang BH; Tardif JC; Shi Y; Dupuis J
    Eur Respir J; 2011 Mar; 37(3):578-86. PubMed ID: 20595149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spironolactone alleviates late cardiac remodeling after left ventricular restoration surgery.
    Tsukashita M; Marui A; Nishina T; Yoshikawa E; Kanemitsu H; Wang J; Ikeda T; Komeda M
    J Thorac Cardiovasc Surg; 2008 Jul; 136(1):58-64. PubMed ID: 18603054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone inhibition and cardiovascular protection: more important than it once appeared.
    Martinez FA
    Cardiovasc Drugs Ther; 2010 Aug; 24(4):345-50. PubMed ID: 20676926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of early aldosterone antagonism on cardiac remodeling in rats with aortic stenosis-induced pressure overload.
    Okoshi MP; Cezar MDM; Iyomasa RM; Silva MB; Costa LCO; Martinez PF; Campos DHS; Damatto RL; Minicucci MF; Cicogna AC; Okoshi K
    Int J Cardiol; 2016 Nov; 222():569-575. PubMed ID: 27513653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spironolactone improves carotid artery fibrosis and distensibility in rat post-ischaemic heart failure.
    Nehme JA; Lacolley P; Labat C; Challande P; Robidel E; Perret C; Leenhardt A; Safar ME; Delcayre C; Milliez P
    J Mol Cell Cardiol; 2005 Sep; 39(3):511-9. PubMed ID: 15992819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of eplerenone on transcriptional factors and mRNA expression related to cardiac remodelling after myocardial infarction.
    Enomoto S; Yoshiyama M; Omura T; Matsumoto R; Kusuyama T; Kim S; Izumi Y; Akioka K; Iwao H; Takeuchi K; Yoshikawa J
    Heart; 2005 Dec; 91(12):1595-600. PubMed ID: 15797934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of spironolactone alone and in addition to a β-blocker on myocardial histological and electrical remodeling in chronic severe failing rat hearts.
    Milliez P; Gomes S; Champ-Rigot L; Callebert J; Samuel JL; Delcayre C
    J Cardiovasc Pharmacol; 2012 Sep; 60(3):315-21. PubMed ID: 22710814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of cardiac remodeling after myocardial infarction in transgenic rats deficient in brain angiotensinogen.
    Lal A; Veinot JP; Ganten D; Leenen FH
    J Mol Cell Cardiol; 2005 Sep; 39(3):521-9. PubMed ID: 15950985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mineralocorticoid receptor antagonist spironolactone improves left ventricular remodeling in patients with congestive heart failure and acute myocardial infarction].
    Tsutamoto T
    Nihon Yakurigaku Zasshi; 2004 Aug; 124(2):90-100. PubMed ID: 15277727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of spironolactone and eprosartan on cardiac remodeling and angiotensin-converting enzyme isoforms in rats with experimental heart failure.
    Karram T; Abbasi A; Keidar S; Golomb E; Hochberg I; Winaver J; Hoffman A; Abassi Z
    Am J Physiol Heart Circ Physiol; 2005 Oct; 289(4):H1351-8. PubMed ID: 15894569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction.
    Fraccarollo D; Galuppo P; Schmidt I; Ertl G; Bauersachs J
    Cardiovasc Res; 2005 Jul; 67(1):97-105. PubMed ID: 15949473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.